Last reviewed · How we verify
NCT05219656: Cyclo
Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.
trial testing Cyclosporine A in Ulcerative Colitis Acute in 182 participants. Completed in 1 January 2022.
30 December 2018
Quick facts
| Lead sponsor | Tampere University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 182 |
| Start date | 1 January 2009 |
| Primary completion | 30 December 2018 |
| Estimated completion | 1 January 2022 |
Drugs / interventions tested
- Cyclosporine A — full drug profile →
Conditions studied
- Ulcerative Colitis Acute — all drugs for Ulcerative Colitis Acute →
Sponsor
Tampere University Hospital
Who can join
16 and older, any sex, with Ulcerative Colitis Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The efficacy and safety of Cyclosporine A as rescue therapy for acute severe ulcerative colitis in long-term follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05219656
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cyclosporine A
Trials testing the same drug.
- NCT06658002 — Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A · Phase 3 · recruiting
- NCT05323617 — Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Thera · Phase 2 · withdrawn
- NCT06512766 — a Retrospective Study on the Systemic Treatment of LPP and FFA · completed
- NCT04877288 — A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to · Phase 3 · recruiting
- NCT04470804 — Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA · Phase 4 · completed
Other recruiting trials for Ulcerative Colitis Acute
Currently open trials in the same condition.
- NCT05466890 — Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) · Phase 2 · active not recruiting
Other Tampere University Hospital trials
Trials by the same sponsor.
- NCT07315568 — Couples and Microbial Diversity · not yet recruiting
- NCT07128992 — Need-driven Treatment of the Patients With Type 1 Diabetes · not yet recruiting
- NCT07042139 — No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older · NA · recruiting
- NCT07528833 — Health Effects of Mindfulness Based Stress Reduction Course in Treatment of Back Pain · NA · recruiting
- NCT06711796 — Measurement of Muscle Relaxation of the Hand in From Two Muscles and Two Hand Positions · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05219656 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tampere University Hospital
- Last refreshed: 2 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219656.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing